What is Force Therapeutics?
Founded in 2010 and headquartered in New York City, Force Therapeutics operates as a specialized remote monitoring platform designed to optimize outcomes for patients undergoing orthopedic procedures. By integrating digital navigation tools with virtual rehabilitation protocols, the company provides health systems with a comprehensive suite for outcomes collection and clinical analytics. The platform serves as a critical digital bridge, allowing providers to maintain continuous oversight of patient progress, thereby reducing readmission rates and improving the overall efficiency of the surgical recovery pathway. Through its sophisticated software architecture, Force Therapeutics enables healthcare organizations to deliver personalized care at scale, effectively digitizing the traditional rehabilitation experience.
How much funding has Force Therapeutics raised?
Force Therapeutics has raised a total of $25.8M across 3 funding rounds:
Private Equity
$2.2M
Private Equity
$2.6M
Private Equity
$21M
Private Equity (2013): $2.2M, investors not publicly disclosed
Private Equity (2016): $2.6M, investors not publicly disclosed
Private Equity (2018): $21M supported by Insight Venture Partners
Key Investors in Force Therapeutics
Insight Venture Partners
A prominent global venture capital and private equity firm that focuses on high-growth software and internet-enabled businesses, providing deep operational support to scale portfolio companies.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Force Therapeutics?
With the support of its latest capital injection, Force Therapeutics is well-positioned to accelerate its enterprise-level expansion. The strategic roadmap likely involves deepening its integration with existing electronic health record systems and enhancing its predictive analytics capabilities to provide more granular insights into patient recovery trajectories. As the healthcare industry continues to shift toward value-based care models, the company's ability to demonstrate measurable improvements in clinical outcomes will be paramount. Future growth will likely focus on broadening its therapeutic scope beyond orthopedics, leveraging its established digital infrastructure to address a wider array of chronic and post-acute care requirements, thereby cementing its role as a foundational element of the modern digital health ecosystem.
See full Force Therapeutics company page
